Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

Inhibition of the Maillard Reaction by Phytochemicals Composing an Aqueous Coffee Silverskin Extract via a Mixed Mechanism of Action.

Rebollo-Hernanz M, Fernández-Gómez B, Herrero M, Aguilera Y, Martín-Cabrejas MA, Uribarri J, Del Castillo MD.

Foods. 2019 Sep 25;8(10). pii: E438. doi: 10.3390/foods8100438.

2.

Alkali delivery in chronic hemodialysis: Would more acetate be helpful?

Uribarri J, Oh MS.

Semin Dial. 2019 May;32(3):229-231. doi: 10.1111/sdi.12791. Epub 2019 Apr 1.

PMID:
30937978
3.

In vitro formation of Maillard reaction products during simulated digestion of meal-resembling systems.

Martinez-Saez N, Fernandez-Gomez B, Cai W, Uribarri J, Del Castillo MD.

Food Res Int. 2019 Apr;118:72-80. doi: 10.1016/j.foodres.2017.09.056. Epub 2017 Sep 21.

PMID:
30898355
4.

Dietary Phosphate and the Forgotten Kidney Patient: A Critical Need for FDA Regulatory Action.

Calvo MS, Sherman RA, Uribarri J.

Am J Kidney Dis. 2019 Apr;73(4):542-551. doi: 10.1053/j.ajkd.2018.11.004. Epub 2019 Jan 25.

PMID:
30686528
5.

Patient-Centric User-Interface in Automated Peritoneal Dialysis: Impact on Training and Outcomes at a Single Center.

Sharma S, Kattamanchi S, Gonzales MG, Sloand JA, Uribarri J.

Blood Purif. 2019;48(2):138-141. doi: 10.1159/000495341. Epub 2019 Jan 2.

PMID:
30602155
6.

Fecal microbiota analysis of polycystic kidney disease patients according to renal function: A pilot study.

Yacoub R, Nadkarni GN, McSkimming DI, Chaves LD, Abyad S, Bryniarski MA, Honan AM, Thomas SA, Gowda M, He JC, Uribarri J.

Exp Biol Med (Maywood). 2019 Apr;244(6):505-513. doi: 10.1177/1535370218818175. Epub 2018 Dec 12.

PMID:
30539656
7.

Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention.

Walter KR, Ford ME, Gregoski MJ, Kramer RM, Knight KD, Spruill L, Nogueira LM, Krisanits BA, Phan V, La Rue AC, Lilly MB, Ambs S, Chan K, Turner TF, Varner H, Singh S, Uribarri J, Garrett-Mayer E, Armeson KE, Hilton EJ, Clair MJ, Taylor MH, Abbott AM, Findlay VJ, Peterson LL, Magwood G, Turner DP.

Breast Cancer Res Treat. 2019 Feb;173(3):559-571. doi: 10.1007/s10549-018-4992-7. Epub 2018 Oct 27.

8.

Advanced glycation end products and their receptors did not show any association with body mass parameters in metabolically healthy adolescents.

Garay-Sevilla ME, Torres-Graciano S, Villegas-Rodríguez ME, Rivera-Cisneros AE, Wrobel K, Uribarri J.

Acta Paediatr. 2018 Dec;107(12):2146-2151. doi: 10.1111/apa.14426. Epub 2018 Jun 19.

PMID:
29846968
9.

Changes in circulating levels of carboxymethyllysine, soluble receptor for advanced glycation end products (sRAGE), and inflammation markers in women during normal pregnancy.

Quintanilla-García CV, Uribarri J, Fajardo-Araujo ME, Barrientos-Romero JJ, Romero-Gutiérrez G, Reynaga-Ornelas MG, Garay-Sevilla ME.

J Matern Fetal Neonatal Med. 2018 Jun 25:1-6. doi: 10.1080/14767058.2018.1481948. [Epub ahead of print]

PMID:
29804482
10.

An aspirational diet for dialysis patients: Evidence and theory.

Uribarri J.

Semin Dial. 2018 May;31(3):236-243. doi: 10.1111/sdi.12697. Epub 2018 Apr 13. Review.

PMID:
29652109
11.

Nutritional Management of Chronic Kidney Disease.

Uribarri J.

N Engl J Med. 2018 Feb 8;378(6):583. doi: 10.1056/NEJMc1715765. No abstract available.

PMID:
29419274
12.

Comparative evaluation of three different ELISA assays and HPLC-ESI-ITMS/MS for the analysis of Nε-carboxymethyl lysine in food samples.

Gómez-Ojeda A, Jaramillo-Ortíz S, Wrobel K, Wrobel K, Barbosa-Sabanero G, Luevano-Contreras C, de la Maza MP, Uribarri J, Del Castillo MD, Garay-Sevilla ME.

Food Chem. 2018 Mar 15;243:11-18. doi: 10.1016/j.foodchem.2017.09.098. Epub 2017 Sep 20.

PMID:
29146316
13.

Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial.

Yacoub R, Nugent M, Cai W, Nadkarni GN, Chaves LD, Abyad S, Honan AM, Thomas SA, Zheng W, Valiyaparambil SA, Bryniarski MA, Sun Y, Buck M, Genco RJ, Quigg RJ, He JC, Uribarri J.

PLoS One. 2017 Sep 20;12(9):e0184789. doi: 10.1371/journal.pone.0184789. eCollection 2017.

14.

Reasons for admission and predictors of national 30-day readmission rates in patients with end-stage renal disease on peritoneal dialysis.

Chan L, Poojary P, Saha A, Chauhan K, Ferrandino R, Ferket B, Coca S, Nadkarni G, Uribarri J.

Clin Kidney J. 2017 Aug;10(4):552-559. doi: 10.1093/ckj/sfx011. Epub 2017 Mar 15.

15.

Consumption of diets with low advanced glycation end products improves cardiometabolic parameters: meta-analysis of randomised controlled trials.

Baye E, Kiriakova V, Uribarri J, Moran LJ, de Courten B.

Sci Rep. 2017 May 23;7(1):2266. doi: 10.1038/s41598-017-02268-0.

16.

Increased odds of metabolic syndrome with consumption of high dietary advanced glycation end products in adolescents.

Saha A, Poojary P, Chan L, Chauhan K, Nadkarni G, Coca S, Uribarri J.

Diabetes Metab. 2017 Oct;43(5):469-471. doi: 10.1016/j.diabet.2017.01.001. Epub 2017 Feb 1. No abstract available.

17.

Geographical Variation in Peritoneal Dialysis Catheter Insertion and Initiation within the United States.

Patel A, Shah H, Patel S, Nadkarni GN, Uribarri J.

Perit Dial Int. 2016 11-12;36(6):691-693.

18.

The link between soda intake and asthma: science points to the high-fructose corn syrup, not the preservatives: a commentary.

DeChristopher LR, Uribarri J, Tucker KL.

Nutr Diabetes. 2016 Nov 28;6(11):e234. doi: 10.1038/nutd.2016.46.

19.

Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial.

Vlassara H, Cai W, Tripp E, Pyzik R, Yee K, Goldberg L, Tansman L, Chen X, Mani V, Fayad ZA, Nadkarni GN, Striker GE, He JC, Uribarri J.

Diabetologia. 2016 Oct;59(10):2181-92. doi: 10.1007/s00125-016-4053-x. Epub 2016 Jul 29.

20.

The AGE-RAGE Axis and Its Relationship to Markers of Cardiovascular Disease in Newly Diagnosed Diabetic Patients.

Villegas-Rodríguez ME, Uribarri J, Solorio-Meza SE, Fajardo-Araujo ME, Cai W, Torres-Graciano S, Rangel-Salazar R, Wrobel K, Garay-Sevilla ME.

PLoS One. 2016 Jul 19;11(7):e0159175. doi: 10.1371/journal.pone.0159175. eCollection 2016.

21.

A Retrospective Study in Adults with Metabolic Syndrome: Diabetic Risk Factor Response to Daily Consumption of Agaricus bisporus (White Button Mushrooms).

Calvo MS, Mehrotra A, Beelman RB, Nadkarni G, Wang L, Cai W, Goh BC, Kalaras MD, Uribarri J.

Plant Foods Hum Nutr. 2016 Sep;71(3):245-51. doi: 10.1007/s11130-016-0552-7.

PMID:
27193019
22.

Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children.

Gupta A, Uribarri J.

Horm Res Paediatr. 2016;85(5):291-300. doi: 10.1159/000444053. Epub 2016 Mar 19. Review.

23.
24.

Association between probiotic and yogurt consumption and kidney disease: insights from NHANES.

Yacoub R, Kaji D, Patel SN, Simoes PK, Busayavalasa D, Nadkarni GN, He JC, Coca SG, Uribarri J.

Nutr J. 2016 Jan 27;15:10. doi: 10.1186/s12937-016-0127-3.

25.

Outcomes of dialysis catheters placed by the Y-TEC peritoneoscopic technique: a single-center surgical experience.

Al Azzi Y, Zeldis E, Nadkarni GN, Schanzer H, Uribarri J.

Clin Kidney J. 2016 Feb;9(1):158-61. doi: 10.1093/ckj/sfv113. Epub 2015 Nov 14.

26.

High dietary advanced glycation end products are associated with poorer spatial learning and accelerated Aβ deposition in an Alzheimer mouse model.

Lubitz I, Ricny J, Atrakchi-Baranes D, Shemesh C, Kravitz E, Liraz-Zaltsman S, Maksin-Matveev A, Cooper I, Leibowitz A, Uribarri J, Schmeidler J, Cai W, Kristofikova Z, Ripova D, LeRoith D, Schnaider-Beeri M.

Aging Cell. 2016 Apr;15(2):309-16. doi: 10.1111/acel.12436. Epub 2016 Jan 19.

27.

Intake of high fructose corn syrup sweetened soft drinks is associated with prevalent chronic bronchitis in U.S. Adults, ages 20-55 y.

DeChristopher LR, Uribarri J, Tucker KL.

Nutr J. 2015 Oct 16;14:107. doi: 10.1186/s12937-015-0097-x.

28.

Dietary advanced glycation end products and their role in health and disease.

Uribarri J, del Castillo MD, de la Maza MP, Filip R, Gugliucci A, Luevano-Contreras C, Macías-Cervantes MH, Markowicz Bastos DH, Medrano A, Menini T, Portero-Otin M, Rojas A, Sampaio GR, Wrobel K, Wrobel K, Garay-Sevilla ME.

Adv Nutr. 2015 Jul 15;6(4):461-73. doi: 10.3945/an.115.008433. Print 2015 Jul. Review.

29.

Reduction of serum advanced glycation end-products with a low calorie Mediterranean diet.

Rodríguez JM, Leiva Balich L, Concha MJ, Mizón C, Bunout Barnett D, Barrera Acevedo G, Hirsch Birn S, Jiménez Jaime T, Henríquez S, Uribarri J, de la Maza Cave MP.

Nutr Hosp. 2015 Jun 1;31(6):2511-7. doi: 10.3305/nh.2015.31.6.8936.

30.

Serum creatinine is not the end-all, be-all of renal impairment.

Mallipattu SK, Ling J, Uribarri J.

Intern Med J. 2015 May;45(5):588. doi: 10.1111/imj.12733. No abstract available.

PMID:
25955467
31.

The low AGE diet: a neglected aspect of clinical nephrology practice?

Uribarri J, He JC.

Nephron. 2015;130(1):48-53. doi: 10.1159/000381315. Epub 2015 Apr 2. Review.

32.

Intakes of apple juice, fruit drinks and soda are associated with prevalent asthma in US children aged 2-9 years.

DeChristopher LR, Uribarri J, Tucker KL.

Public Health Nutr. 2016 Jan;19(1):123-30. doi: 10.1017/S1368980015000865. Epub 2015 Apr 10.

PMID:
25857343
33.

Effect of an advanced glycation end product-restricted diet and exercise on metabolic parameters in adult overweight men.

Macías-Cervantes MH, Rodríguez-Soto JM, Uribarri J, Díaz-Cisneros FJ, Cai W, Garay-Sevilla ME.

Nutrition. 2015 Mar;31(3):446-51. doi: 10.1016/j.nut.2014.10.004. Epub 2014 Nov 1.

34.

Elevated serum advanced glycation endproducts in obese indicate risk for the metabolic syndrome: a link between healthy and unhealthy obesity?

Uribarri J, Cai W, Woodward M, Tripp E, Goldberg L, Pyzik R, Yee K, Tansman L, Chen X, Mani V, Fayad ZA, Vlassara H.

J Clin Endocrinol Metab. 2015 May;100(5):1957-66. doi: 10.1210/jc.2014-3925. Epub 2015 Feb 19.

35.

Effect of cholecalciferol supplementation on inflammation and cellular alloimmunity in hemodialysis patients: data from a randomized controlled pilot trial.

Li L, Lin M, Krassilnikova M, Ostrow K, Bader A, Radbill B, Uribarri J, Tokita J, Leisman S, Lapsia V, Albrecht RA, García-Sastre A, Branch AD, Heeger PS, Mehrotra A.

PLoS One. 2014 Oct 8;9(10):e109998. doi: 10.1371/journal.pone.0109998. eCollection 2014.

36.

Manifold exchange: a delivery option in managing patients on peritoneal dialysis.

Mallipattu S, Duffoo M, Fallahi A, Uribarri J.

Perit Dial Int. 2014 Sep-Oct;34(6):657-63. doi: 10.3747/pdi.2013.00205. No abstract available.

37.

Advanced glycation end product accumulation: a new enemy to target in chronic kidney disease?

Mallipattu SK, Uribarri J.

Curr Opin Nephrol Hypertens. 2014 Nov;23(6):547-54. doi: 10.1097/MNH.0000000000000062. Review.

38.

Bioavailability of vitamin D2 from enriched mushrooms in prediabetic adults: a randomized controlled trial.

Mehrotra A, Calvo MS, Beelman RB, Levy E, Siuty J, Kalaras MD, Uribarri J.

Eur J Clin Nutr. 2014 Oct;68(10):1154-60. doi: 10.1038/ejcn.2014.157. Epub 2014 Aug 13.

PMID:
25117997
39.

Dietary advanced glycation end products are associated with decline in memory in young elderly.

West RK, Moshier E, Lubitz I, Schmeidler J, Godbold J, Cai W, Uribarri J, Vlassara H, Silverman JM, Beeri MS.

Mech Ageing Dev. 2014 Sep;140:10-2. doi: 10.1016/j.mad.2014.07.001. Epub 2014 Jul 15.

40.

Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans.

Cai W, Uribarri J, Zhu L, Chen X, Swamy S, Zhao Z, Grosjean F, Simonaro C, Kuchel GA, Schnaider-Beeri M, Woodward M, Striker GE, Vlassara H.

Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4940-5. doi: 10.1073/pnas.1316013111. Epub 2014 Feb 24.

41.

Introduction to dietary phosphorus excess and health.

Uribarri J, Calvo MS.

Ann N Y Acad Sci. 2013 Oct;1301:iii-iv. doi: 10.1111/nyas.12302. No abstract available.

42.

Phosphorus and the kidney: What is known and what is needed.

Nadkarni GN, Uribarri J.

Adv Nutr. 2014 Jan 1;5(1):98-103. doi: 10.3945/an.113.004655. Review.

43.

What can we learn from the saga of chitosan gums in hyperphosphatemia therapy?

Oh MS, Uribarri J.

Clin J Am Soc Nephrol. 2014 May;9(5):967-70. doi: 10.2215/CJN.09230913. Epub 2014 Jan 9.

44.

Dietary phosphorus intake and health1-3.

Uribarri J, Calvo MS.

Am J Clin Nutr. 2014 Feb;99(2):247-8. doi: 10.3945/ajcn.113.080259. Epub 2013 Dec 31. No abstract available.

PMID:
24381089
45.

Advanced glycation end products (AGE) and diabetes: cause, effect, or both?

Vlassara H, Uribarri J.

Curr Diab Rep. 2014 Jan;14(1):453. doi: 10.1007/s11892-013-0453-1. Review.

46.

Potassium balance in dialysis patients.

Sanghavi S, Whiting S, Uribarri J.

Semin Dial. 2013 Sep-Oct;26(5):597-603. doi: 10.1111/sdi.12123. Review.

PMID:
24073843
47.

Dietary phosphorus excess: a risk factor in chronic bone, kidney, and cardiovascular disease?

Uribarri J, Calvo MS.

Adv Nutr. 2013 Sep 1;4(5):542-4. doi: 10.3945/an.113.004234.

48.

Dietary phosphorus and kidney disease.

Uribarri J.

Ann N Y Acad Sci. 2013 Oct;1301:11-9. doi: 10.1111/nyas.12201. Epub 2013 Jul 22. Review.

49.

Public health impact of dietary phosphorus excess on bone and cardiovascular health in the general population.

Calvo MS, Uribarri J.

Am J Clin Nutr. 2013 Jul;98(1):6-15. doi: 10.3945/ajcn.112.053934. Epub 2013 May 29. Review.

PMID:
23719553
50.

Combined and independent impact of diabetes mellitus and chronic kidney disease on residual platelet reactivity.

Baber U, Bander J, Karajgikar R, Yadav K, Hadi A, Theodoropolous K, Gukathasan N, Roy S, Sayeneni S, Scott SA, Kovacic JC, Yu J, Sartori S, Mehran R, Uribarri J, Badimon JJ, Muntner P, Moreno P, Kini AS, Sharma SK.

Thromb Haemost. 2013 Jul;110(1):118-23. doi: 10.1160/TH13-01-0004. Epub 2013 May 16.

PMID:
23677380

Supplemental Content

Loading ...
Support Center